NCT01229735 Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures Status COMPLETED Phase PHASE4
NCT01228747 A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures) Status COMPLETED Phase PHASE3
NCT01132352 Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions Status COMPLETED Phase PHASE1
NCT01131897 Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions. Status COMPLETED Phase PHASE1
NCT01063764 An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures Status COMPLETED Phase PHASE3
NCT00862563 Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism Status TERMINATED Phase PHASE2
NCT00827320 Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions Status COMPLETED Phase NA
NCT00826865 Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions Status COMPLETED Phase NA
NCT00826787 Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions Status COMPLETED Phase NA
NCT00826722 Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions Status COMPLETED Phase NA
NCT00736931 Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam Status COMPLETED Phase PHASE1
NCT00643500 Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy Status COMPLETED Phase PHASE4